WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19 February 11, 2022February 22, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: WHO grants prequalification of Actemra/RoActemra for…CHMP recommends EU approval of Actemra/RoActemra to…Actemra/RoActemra approved by the European…U.S. FDA grants priority review to Roche’s…Roche’s Actemra/RoActemra receives U.S. FDA…FDA approves Roche’s Actemra for the treatment of…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
